MIRM vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

MIRM

58.8
AI Score
VS
SYRE Wins

SYRE

66.4
AI Score

Investment Advisor Scores

MIRM

Sep 12, 2026
59score
Recommendation
BUY

SYRE

Sep 12, 2026
66score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MIRM SYRE Winner
Forward P/E 181.8182 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 37.9% 0.0% MIRM
Earnings Growth 0.0% -99.7% MIRM
Tradestie Score 58.8/100 66.4/100 SYRE
Profit Margin -139.2% 0.0% SYRE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY HOLD MIRM

Relative Price Performance (Last 90 Days)

MIRM 1M: -0.8% · 3M: -1.3% SYRE 1M: -13.0% · 3M: +12.2%

Current Technical Phase

MIRM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.3%), weak momentum, RSI 44

RSI (14): 44.1 · Price: $98.22

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $90.60

Fundamentals Snapshot

Metric MIRM SYRE
Market Cap
Forward P/E -283.3 -25.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% 0.0%
Gross Margin 0.8%
Operating Margin -0.1% 0.0%
EPS -14.41 -1.96
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.